Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-21

Clinical Trial Update: Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain [Phase 4]

View source ↗

Summary

Phase 4 trial comparing buprenorphine with escalating opioid doses in adults with chronic pain was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Opioids (opioid)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Pain | Phase 4 | Status: TERMINATED | Results posted: 2016-12-21